ANI Pharmaceuticals Inc (ANIP)

ANI Pharmaceuticals (ANIP) Financial Statements


ANI Pharmaceuticals Financial Overview

ANI Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-3.051; its P/E ratio is -13.06; ANI Pharmaceuticals is scheduled to report earnings on May 9, 2023, and the estimated EPS forecast is $0.35. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 94.23M$ 83.82M$ 73.86M$ 64.48M$ 60.93M
Gross Profit$ 57.91M$ 50.93M$ 38.56M$ 30.21M$ 27.03M
EBIT$ 1.78M$ -4.96M$ -12.15M$ -19.28M$ -26.41M
EBITDA$ 17.35M$ 10.39M$ 2.02M$ -4.73M$ -12.73M
Net Income Common Stockholders$ -4.65M$ -9.01M$ -15.33M$ -20.54M$ -24.33M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 48.23M$ 56.28M$ 63.38M$ 76.91M$ 100.30M
Total Assets$ 760.09M$ 739.11M$ 751.33M$ 744.85M$ 771.60M
Total Debt$ 286.52M$ 286.73M$ 286.94M$ 287.16M$ 287.37M
Net Debt$ 238.29M$ 230.45M$ 223.56M$ 210.25M$ 187.07M
Total Liabilities$ 421.55M$ 402.44M$ 414.38M$ 398.75M$ 412.86M
Stockholders Equity$ 338.54M$ 336.68M$ 336.96M$ 346.09M$ 358.74M
Cash Flow-
Free Cash Flow$ -7.54M$ -6.19M$ -12.80M$ -21.12M$ -12.55M
Operating Cash Flow$ -4.40M$ 3.62M$ -11.48M$ -18.94M$ -12.19M
Investing Cash Flow$ -3.14M$ -9.81M$ -604.00K$ -2.18M$ -82.21M
Financing Cash Flow$ -508.00K$ -911.00K$ -1.44M$ -2.27M$ 179.44M
Currency in USD

ANI Pharmaceuticals Earnings and Revenue History

ANI Pharmaceuticals Debt to Assets

ANI Pharmaceuticals Cash Flow

ANI Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis